Annual EBITDA
-$101.68 M
-$40.68 M-66.69%
31 December 2023
Summary:
Terns Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$101.68 million, with the most recent change of -$40.68 million (-66.69%) on 31 December 2023. During the last 3 years, it has fallen by -$65.05 million (-177.57%). TERN annual EBITDA is now -452.89% below its all-time high of -$18.39 million, reached on 31 December 2018.TERN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$24.73 M
+$564.00 K+2.23%
30 September 2024
Summary:
Terns Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$24.73 million, with the most recent change of +$564.00 thousand (+2.23%) on 30 September 2024. Over the past year, it has increased by +$8.23 million (+24.97%). TERN quarterly EBITDA is now -186.39% below its all-time high of -$8.64 million, reached on 30 September 2020.TERN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$99.08 M
+$8.23 M+7.67%
30 September 2024
Summary:
Terns Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$99.08 million, with the most recent change of +$8.23 million (+7.67%) on 30 September 2024. Over the past year, it has dropped by -$4.64 million (-4.92%). TERN TTM EBITDA is now -903.73% below its all-time high of -$9.87 million, reached on 31 December 2019.TERN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TERN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.7% | +25.0% | -4.9% |
| 3 y3 years | -177.6% | -110.3% | -123.9% |
| 5 y5 years | -452.9% | - | - |
TERN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -177.6% | at low | -110.3% | +25.0% | -123.9% | +7.7% |
| 5 y | 5 years | -452.9% | at low | -186.4% | +25.0% | -903.7% | +7.7% |
| alltime | all time | -452.9% | at low | -186.4% | +25.0% | -903.7% | +7.7% |
Terns Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.73 M(-2.2%) | -$99.08 M(-7.7%) |
| June 2024 | - | -$25.30 M(+0.3%) | -$107.31 M(+4.2%) |
| Mar 2024 | - | -$25.21 M(+5.8%) | -$102.95 M(+1.3%) |
| Dec 2023 | -$101.68 M(+66.7%) | -$23.84 M(-27.7%) | -$101.68 M(+7.7%) |
| Sept 2023 | - | -$32.96 M(+57.4%) | -$94.43 M(+20.3%) |
| June 2023 | - | -$20.94 M(-12.5%) | -$78.51 M(+10.0%) |
| Mar 2023 | - | -$23.93 M(+44.2%) | -$71.39 M(+17.0%) |
| Dec 2022 | -$61.00 M | -$16.59 M(-2.6%) | -$61.00 M(+4.9%) |
| Sept 2022 | - | -$17.04 M(+23.3%) | -$58.17 M(+10.0%) |
| June 2022 | - | -$13.81 M(+2.0%) | -$52.89 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.55 M(-1.6%) | -$49.77 M(+0.9%) |
| Dec 2021 | -$49.35 M(+34.7%) | -$13.76 M(+17.0%) | -$49.35 M(+11.5%) |
| Sept 2021 | - | -$11.76 M(+9.9%) | -$44.25 M(+7.6%) |
| June 2021 | - | -$10.70 M(-18.5%) | -$41.12 M(+1.7%) |
| Mar 2021 | - | -$13.12 M(+51.5%) | -$40.42 M(+10.3%) |
| Dec 2020 | -$36.63 M(-47.7%) | -$8.66 M(+0.3%) | -$36.63 M(-3.2%) |
| Sept 2020 | - | -$8.64 M(-13.6%) | -$37.84 M(+29.6%) |
| June 2020 | - | -$10.00 M(+7.1%) | -$29.20 M(+52.1%) |
| Mar 2020 | - | -$9.34 M(-5.4%) | -$19.21 M(+94.6%) |
| Dec 2019 | -$70.00 M(+280.7%) | -$9.87 M | -$9.87 M |
| Dec 2018 | -$18.39 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual EBITDA year-on-year change?
- What is Terns Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Terns Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM EBITDA year-on-year change?
What is Terns Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TERN is -$101.68 M
What is the all time high annual EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$18.39 M
What is Terns Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, TERN annual earnings before interest, taxes, depreciation & amortization has changed by -$40.68 M (-66.69%)
What is Terns Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TERN is -$24.73 M
What is the all time high quarterly EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$8.64 M
What is Terns Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, TERN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$8.23 M (+24.97%)
What is Terns Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TERN is -$99.08 M
What is the all time high TTM EBITDA for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.87 M
What is Terns Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, TERN TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.64 M (-4.92%)